藥物球囊治療冠狀動(dòng)脈血管病變的療效觀察
【摘要】目的:觀察藥物球囊治療冠狀動(dòng)脈血管病變的療效。方法:選取本院2022年2月—2023年2月接收的60例冠狀動(dòng)脈血管病變患者,將其隨機(jī)分為對(duì)照組和觀察組,每組30例,對(duì)照組采用DES(藥物洗脫支架)介入治療,觀察組采用藥物球囊治療,對(duì)比兩組治療效果。結(jié)果:兩組治療前管腔狹窄程度、MLD(最小血管內(nèi)徑)及生活質(zhì)量評(píng)分比較均無明顯差異(P>0.05);治療后,觀察組管腔狹窄程度及生活質(zhì)量評(píng)分均高于對(duì)照組,MLD低于對(duì)照組(P
【關(guān)鍵詞】血管病變;冠狀動(dòng)脈;藥物球囊;療效
Observation on the therapeutic effect of drug balloon therapy on coronary artery vascular lesions
RAO Tingbin, LI Hongyao, JIA Yunxia, LUO Maowei, LI Yichuan
Department of Cardiology, Suiyang County Hospital of Traditional Chinese Medicine, Guizhou, Zunyi, Guizhou 563300, China
【Abstract】Objective:To observe the therapeutic effect of drug balloon therapy on coronary artery disease.Methods:Sixty patients with coronary artery vascular lesions admitted to our hospital from February 2022 to February 2023 were selected and randomlydivided into the control group and the observation group,with 30 patients in each group.The control group received DES (drug eluting stent) intervention treatment,while the observation group received drug balloon therapy.The treatment effects of the two groups were compared.Results:There was no significant difference in the degree of luminal stenosis,MLD (minimal luminal diameter) and quality of life scores between the two groups before treatment (P>0.05);After treatment,the degree of luminal stenosis and quality of life scores in the observation group were higher than those in the control group,MLD was lower than that in the control group (P
【Key Words】Vascular lesions;Coronary artery;Drug balloon;Curative effect
現(xiàn)階段,臨床治療冠狀動(dòng)脈血管病變的常用方案之一即支架植入,但具有一定的應(yīng)用局限,雖然新一代DES介入治療可使患者發(fā)生支架內(nèi)再狹窄的概率明顯降低,但術(shù)后仍易引發(fā)破裂等,從而對(duì)最終的治療效果產(chǎn)生影響[1-2]。(剩余3718字)
- 婚前體檢與孕前體檢資源聯(lián)合應(yīng)用...
- 營養(yǎng)教育指導(dǎo)對(duì)孕婦營養(yǎng)狀況及妊...
- 優(yōu)質(zhì)護(hù)理在初產(chǎn)婦剖宮產(chǎn)后母乳喂...
- 新生兒乳房爬行運(yùn)動(dòng)對(duì)陰道分娩初...
- 無痛人工流產(chǎn)術(shù)靜脈復(fù)合麻醉臨床...
- 無痛分娩護(hù)理干預(yù)對(duì)產(chǎn)婦產(chǎn)程及疼...
- 妊娠早期飲食與運(yùn)動(dòng)干預(yù)對(duì)妊娠期...
- 子宮收縮乏力性產(chǎn)后出血患者應(yīng)用...
- ER、PR和p53在子宮內(nèi)膜癌...
- 探究對(duì)子宮肌瘤患者實(shí)施基于風(fēng)險(xiǎn)...
- 實(shí)時(shí)熒光人乳頭瘤病毒檢測和液基...
- 不同免疫檢驗(yàn)方法檢測乙肝病毒感...
- 微創(chuàng)術(shù)與頭戴冰帽、降溫毯聯(lián)用對(duì)...
- CT與X線在腰椎退行性病變中的...
- 血脂及血清GGT-Ⅱ、CRP、...
- 鎖定加壓鋼板內(nèi)固定治療創(chuàng)傷性四...
- 快速血糖儀與常規(guī)生化儀對(duì)血糖檢...
- 呼吸系統(tǒng)感染中白細(xì)胞介素-6及...
- 血管內(nèi)介入治療急性腦梗死的臨床...
- 椎體成形術(shù)治療老年骨質(zhì)疏松性脊...
- 腰椎間盤突出檢查中MRI與CT...
- 聯(lián)合降壓調(diào)脂對(duì)社區(qū)治療老年高血...
- 原發(fā)性IgA腎病患者臨床特點(diǎn)與...
- 淺表軟組織侵襲性纖維瘤病的超聲...
- 藥物球囊治療冠狀動(dòng)脈血管病變的...
- 尿激酶介入性治療急性腦血栓的臨...
- 奧美拉唑腸溶膠囊聯(lián)合硫糖鋁口服...
- 奧拉西坦聯(lián)合丁苯酞治療老年高血...
- 丁苯酞聯(lián)合通心絡(luò)膠囊治療慢性腦...
- 中西醫(yī)結(jié)合治療老年抑郁癥的臨床...
- 頸肩腰腿疼痛患者行中醫(yī)針灸康復(fù)...
- 益氣化痰活血法對(duì)高血壓病患者血...
- 俯臥位通氣的應(yīng)用及護(hù)理要點(diǎn)...
- 針灸聯(lián)合安神湯在肝郁氣結(jié)型失眠...
- 中醫(yī)特色護(hù)理在冠心病重癥醫(yī)學(xué)科...
- 小兒支氣管哮喘急性發(fā)作期綜合護(hù)...
- 綜合護(hù)理干預(yù)在小兒肺炎合并心力...
- 新生兒聽力篩查結(jié)果分析...
- 微創(chuàng)彈性髓內(nèi)針內(nèi)固定治療小兒不...
- 抗生素聯(lián)合氨溴特羅口服溶液在小...
- 規(guī)范護(hù)理配合對(duì)妊娠期糖尿病患者...
- 基于人文關(guān)懷理念的綜合護(hù)理在婦...
- 柔性管理在婦產(chǎn)科護(hù)理中的實(shí)施效...
- 女性不孕癥患者開展敘事護(hù)理服務(wù)...
- 卒中后失語患者采取康復(fù)護(hù)理對(duì)語...
- 預(yù)見性護(hù)理方案對(duì)行造血干細(xì)胞移...
- ERAS理念應(yīng)用于膝關(guān)節(jié)置換患...
- 循證護(hù)理干預(yù)對(duì)細(xì)菌性肝膿腫患者...
- 強(qiáng)化護(hù)理管理對(duì)尿毒癥血液透析患...
- 膽囊結(jié)石圍手術(shù)期護(hù)理中臨床護(hù)理...
- 優(yōu)化手術(shù)護(hù)理配合急救流程在急危...
- 1例結(jié)腸肝曲癌術(shù)后突發(fā)輸液港功...
- 綜合性護(hù)理干預(yù)在甲狀腺癌根治術(shù)...
- 眼科護(hù)理跌倒風(fēng)險(xiǎn)評(píng)估單在低視力...
- 護(hù)理干預(yù)在心臟瓣膜置換術(shù)后護(hù)理...
- 縮減約束護(hù)理模式在ICU氣管插...
- 預(yù)見性護(hù)理預(yù)防宮腔鏡術(shù)后并發(fā)癥...
- 圍術(shù)期快速康復(fù)護(hù)理在微創(chuàng)肝膽外...
- 綜合性護(hù)理干預(yù)在急性胃腸炎患者...
- 重癥監(jiān)護(hù)優(yōu)質(zhì)化護(hù)理干預(yù)對(duì)急性心...
- 三叉神經(jīng)痛患者疼痛護(hù)理干預(yù)的效...
- 腸內(nèi)營養(yǎng)管理路徑在神經(jīng)重癥患者...
- 心理護(hù)理聯(lián)合健康教育對(duì)糖尿病患...
- 心理護(hù)理與健康教育對(duì)高血壓患者...
- 急診危重患者應(yīng)用風(fēng)險(xiǎn)因素管理的...
- 綜合性社區(qū)護(hù)理服務(wù)在居家養(yǎng)老護(hù)...